Dexcom's (DXCM) CGM Gets FDA's Breakthrough Device Designation
4/3 18:10
DexCom, Inc. DXCM recently received the FDA’s Breakthrough Device Designation for the Dexcom continuous glucose monitoring (“CGM”) system’s use in the hospital setting. The designation is expected to offer a more efficient and streamlined review pathway to enable Dexcom C...